斯迪克(300806.SZ):OCA產品及抗衝擊材料方案在各客戶端均取得良好進展
格隆匯7月10日丨斯迪克(300806.SZ)在投資者互動平臺表示,2019年11月登陸資本市場後,斯迪克直面經濟下行壓力,以戰略定力實現了泗洪生產基地的跨越式發展與產業鏈縱向延伸。五年間,公司非流動資產規模從2019年末的10億元攀升至2024年末的51億元,固定資產投資規模擴張至上市前的五倍,爲企業長遠發展築牢根基。斯迪克的OCA產品及抗衝擊材料方案在各客戶端均取得良好進展,其產品性能與參數能夠滿足客戶在摺疊手機、直板手機等不同機型上的多樣化需求。公司在相關產品的研發方面,始終堅持長期且持續的佈局。另外,16#17#相關項目尚在建設中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.